Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -135,789 | -111,985 | -121,287 | -2,318 | -32,177 |
| Depreciation Amortization | 6,122 | 1,277 | 1,525 | 1,300 | 1,463 |
| Accounts receivable | 1,114 | 1,183 | -1,080 | -1,063 | -1,211 |
| Other Working Capital | -22,136 | 12,269 | -5,305 | 6,933 | -350 |
| Other Operating Activity | 22,150 | 32,561 | 96,453 | -28,531 | 17,066 |
| Operating Cash Flow | $-128,539 | $-64,695 | $-29,694 | $-23,679 | $-15,209 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -139,455 | 0 | 0 | N/A | -7 |
| PPE Investments | -25,444 | -2,370 | -108 | -1,178 | -832 |
| Purchase Of Investment | N/A | -7,897 | 0 | N/A | N/A |
| Sale Of Investment | 7,250 | 0 | 0 | N/A | N/A |
| Purchase Sale Intangibles | -1,381 | -1,405 | -1,037 | -1,127 | -1,122 |
| Other Investing Activity | -1,381 | -1,405 | -1,037 | -1,127 | -1,122 |
| Investing Cash Flow | $-159,030 | $-11,672 | $-1,145 | $-2,305 | $-1,961 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -94 | -89 | -85 | -81 | -77 |
| Common Stock Issued | 104,249 | 145,986 | 178,681 | 32,380 | 2,561 |
| Other Financing Activity | 0 | -226 | 0 | 0 | 0 |
| Financing Cash Flow | $104,155 | $145,671 | $178,596 | $32,299 | $2,484 |
| Beginning Cash Position | 256,965 | 187,661 | 39,904 | 33,589 | 48,275 |
| End Cash Position | 73,551 | 256,965 | 187,661 | 39,904 | 33,589 |
| Net Cash Flow | $-183,414 | $69,304 | $147,757 | $6,315 | $-14,686 |
| Free Cash Flow | |||||
| Operating Cash Flow | -128,539 | -64,695 | -29,694 | -23,679 | -15,209 |
| Capital Expenditure | -25,444 | -2,370 | -108 | -1,178 | -832 |
| Free Cash Flow | -153,983 | -67,065 | -29,802 | -24,857 | -16,041 |